Ocean Biomedical(OCEA)
Search documents
Ocean Biomedical(OCEA) - 2023 Q2 - Quarterly Report
2023-08-14 20:05
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Delaware 87-1309280 55 Claverick St., Room 325 Providence, Rhode Island 02903 Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, par value $0.0001 per share OCEA The NASDAQ Stock Market LLC Warrants, each exercisable for one share of common stock at an exercise price of $11.50 OCEAW The NASDAQ Stock Market LLC FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURI ...
Ocean Biomedical(OCEA) - 2023 Q1 - Quarterly Report
2023-05-24 20:26
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____to _____ Commission File Number: 001-40793 Ocean Biomedical, Inc. (Exact name of registrant as specified in its charter) | --- | |----------------------- ...
Ocean Biomedical(OCEA) - 2022 Q4 - Annual Report
2023-03-31 18:33
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____to _____ Commission File Number: 001-40793 Ocean Biomedical, Inc. (Exact name of registrant as specified in its charter) | --- | |------------------------------- ...